Lack of a mechanism for faithful partition and maintenance of the KSHV genome

Virus Research

Volumn 122, Issue 1-2, 2006, Pages 85-94

  Ueda, Keiji ^a   Sakakibara, Shuhei ^a   Ohsaki, Eriko ^a   Yada, Kaori ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bacmid; KSHV; LANA; Latency; Maintenance; Partition; Terminal repeats

Indexed keywords

GENOMIC RNA;

ARTICLE; CELL CULTURE; CELL CYCLE; GENOME; HUMAN HERPESVIRUS 8; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS REPLICATION;

ANTIGENS, VIRAL; CELL LINE; CLONING, MOLECULAR; DNA, VIRAL; GENES, REPORTER; GENETIC VECTORS; GENOME, VIRAL; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 8, HUMAN; HUMANS; MICROSCOPY, FLUORESCENCE; NUCLEAR PROTEINS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 8;

EID: 33750372444     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.07.002     Document Type: Article

References (45)

1. Aiyar A., Tyree C., and Sugden B. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J. 17 21 (1998) 6394-6403
2. Ballestas M.E., Chatis P.A., and Kaye K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284 5414 (1999) 641-644
3. Ballestas M.E., and Kaye K.M. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J. Virol. 75 7 (2001) 3250-3258
4. Boshoff C., Gao S.J., Healy L.E., Matthews S., Thomas A.J., Coignet L., Warnke R.A., Strauchen J.A., Matutes E., Kamel O.W., Moore P.S., Weiss R.A., and Chang Y. Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 91 5 (1998) 1671-1679
5. Cesarman E., Chang Y., Moore P.S., Said J.W., and Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332 18 (1995) 1186-1191
6. Cesarman E., Moore P.S., Rao P.H., Inghirami G., Knowles D.M., and Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86 7 (1995) 2708-2714
7. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., and Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 5192 (1994) 1865-1869
8. Chen J., Ueda K., Sakakibara S., Okuno T., and Yamanishi K. Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene. J. Virol. 74 18 (2000) 8623-8634
9. Chen L., and Lagunoff M. Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells. J. Virol. 79 22 (2005) 14383-14391
10. Cotter II M.A., and Robertson E.S. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264 2 (1999) 254-264
11. Cotter II M.A., Subramanian C., and Robertson E.S. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus. Virology 291 2 (2001) 241-259
12. Dittmer D., Lagunoff M., Renne R., Staskus K., Haase A., and Ganem D. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 72 10 (1998) 8309-8315
13. Gaidano G., and Carbone A. Primary effusion lymphoma: a liquid phase lymphoma of fluid-filled body cavities. Adv. Cancer Res. 80 (2001) 115-146
14. Garber A.C., Hu J., and Renne R. Latency-associated nuclear antigen (LANA) cooperatively binds to two site within the terminal repeat, and both sites contribute to the ability of LANA suppress transcription and to facilitate DNA replication. J. Biol. Chem. 277 (2002) 27401-27411
15. Garber A.C., Shu M.A., Hu J., and Renne R. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75 17 (2001) 7882-7892
16. Grundhoff A., and Ganem D. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest. 113 1 (2004) 124-136
17. Hu J., Garber A.C., and Renne R. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J. Virol. 76 22 (2002) 11677-11687
18. Hu J., and Renne R. Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin. J. Virol. 79 4 (2005) 2637-2642
19. Hung S.C., Kang M.S., and Kieff E. Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. Proc. Natl. Acad. Sci. U.S.A. 98 4 (2001) 1865-1870
20. Katano H., Iwasaki T., Baba N., Terai M., Mori S., Iwamoto A., Kurata T., and Sata T. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J. Virol. 74 8 (2000) 3478-3485
21. Kedes D.H., Operskalski E., Busch M., Kohn R., Flood J., and Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat. Med. 2 8 (1996) 918-924
22. Kieff E., and Rickinson A. Epstein-Barr virus and its replication. In: Knipe D.M., and Howley P.M. (Eds). Field's Virology. fourth ed. vol. 2 (2001), Lippincott-Williams and Wilkins, Philadelphia, PA
23. Kirchmaier A.L., and Sugden B. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J. Virol. 69 2 (1995) 1280-1283
24. Krithivas A., Fujimuro M., Weidner M., Young D.B., and Hayward S.D. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J. Virol. 76 22 (2002) 11596-11604
25. Lew D.J., and Burke D.J. The spindle assembly and spindle position checkpoints. Annu. Rev. Genet. 37 (2003) 251-282
26. Lim C., Sohn H., Lee D., Gwack Y., and Choe J. Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J. Virol. 76 20 (2002) 10320-10331
27. Mackey D., and Sugden B. Studies on the mechanism of DNA linking by Epstein-Barr virus nuclear antigen 1. J. Biol. Chem. 272 47 (1997) 29873-29879
28. Matsumoto Y., Nomura K., Ueda K., Satoh K., Yasuda N., Taki T., Yokota S., Horiike S., Okanoue T., and Taniwaki M. Human herpesvirus 8-negative malignant effusion lymphoma: a distinct clinical entity and successful treatment with rituximab. Leuk. Lymphoma 46 3 (2005) 415-419
29. McDonagh D.P., Liu J., Gaffey M.J., Layfield L.J., Azumi N., and Traweek S.T. Detection of Kaposi's sarcoma-associated herpesvirus-like DNA sequence in angiosarcoma. Am. J. Pathol. 149 4 (1996) 1363-1368
30. Mesri E.A., Cesarman E., Arvanitakis L., Rafii S., Moore M.A., Posnett D.N., Knowles D.M., and Asch A.S. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J. Exp. Med. 183 5 (1996) 2385-2390
31. Moore P.S., and Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?. Annu. Rev. Microbiol. 57 (2003) 609-639
32. Nishimura K., Ueda K., Sakakibara S., Ishikawa K., Chen J., Okuno T., and Yamanishi K. Functional analysis of Kaposi's sarcoma-associated herpesvirus RTA in an RTA-depressed cell line. J. Hum. Virol. 4 6 (2001) 296-305
33. Okuno T., Jiang Y.B., Ueda K., Nishimura K., Tamura T., and Yamanishi K. Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression. Virus Res. 90 1-2 (2002) 77-89
34. Piolot T., Tramier M., Coppey M., Nicolas J.C., and Marechal V. Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J. Virol. 75 8 (2001) 3948-3959
35. Renne R., Blackbourn D., Whitby D., Levy J., and Ganem D. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 72 6 (1998) 5182-5188
36. Renne R., Lagunoff M., Zhong W., and Ganem D. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J. Virol. 70 11 (1996) 8151-8154
37. Rickinson A., and Kieff E. Epstein-Barr Virus. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. fourth ed vol. 2 (2001), Lippincott Williama and Wilkins, Philadelphia, PA
38. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Chang Y., and Moore P.S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U.S.A. 93 25 (1996) 14862-14867
39. Sakakibara S., Ueda K., Nishimura K., Do E., Ohsaki E., Okuno T., and Yamanishi K. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. J. Virol. 78 14 (2004) 7299-7310
40. Shimizu N., Tanabe-Tochikura A., Kuroiwa Y., and Takada K. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J. Virol. 68 9 (1994) 6069-6073
41. Stedman W., Deng Z., Lu F., and Lieberman P.M. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J. Virol. 78 22 (2004) 12566-12575
42. Yates J., Camiolo S.M., and Bashaw J.M. The minimal replicator of Epstein-Barr virus oriP. J. Virol. 74 10 (2000) 4515-4522
43. Yates J., Warren N., and Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313 (1985) 812-815
44. You J., Croyle J.L., Nishimura A., Ozato K., and Howley P.M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117 3 (2004) 349-360
45. Zhou F.C., Zhang Y.J., Deng J.H., Wang X.P., Pan H.Y., Hettler E., and Gao S.J. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J. Virol. 76 12 (2002) 6185-6196